7 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25987375	20	Discovery of a novel Kv7 channel opener as a treatment for epilepsy.	Pfizer
23121096	86	Ion channels as therapeutic targets: a drug discovery perspective.	Pfizer
22793372	66	Discovery of a series of 2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)acetamides as novel molecular switches that modulate modes of K(v)7.2 (KCNQ2) channel pharmacology: identification of (S)-2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a potent, brain penetrant K(v)7.2 channel inhibitor.	Vanderbilt University Medical Center
22910039	66	Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator.	Vanderbilt University Medical Center
31815462	15	Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators.	University Federico Ii of Naples
30655942	13	Discovery of Novel Retigabine Derivatives as Potent KCNQ4 and KCNQ5 Channel Agonists with Improved Specificity.	Chinese Academy of Sciences
30327146	29	Novel K	Glaxosmithkline